Regular cannabis users show no impairment in their driving skills, according to a new study
A new study calls into question one of the most controversial aspects of the fight against driving under the influence of drugs: the question of whether THC blood levels reliably reflect real-life impairment.
The researchers found that regular cannabis users showed no significant decline in simulated driving performance 12 to 15 hours after smoking, Many of them still have THC levels above the legal threshold in the UK. These results, published as a preview in the Journal of Cannabis Research, In addition to the above, the company's own research into the effects of alcohol and other substances on the environment supports the argument that current policies of roadside checks and blood tests could penalize drivers who are not actually drunk.
The study compared 65 regular cannabis users à 65 non-consumers, using a driving simulator to assess various performance indicators. The cannabis-using group had consumed cannabis the evening before, unlike the control group.
«The group of regular cannabis users showed no significant impairment of driving performance 12 to 15 hours after their last cannabis consumption the previous evening, compared with the control group,» the study concludes. «THC concentrations in blood and saliva may not be an accurate indicator of driving behavior.»
THC levels above the legal limit in the UK, but no reduction in driving performance
The average THC concentration in blood in the cannabis-using group remained higher than in the 2 ng/mL, which corresponds to the legal limit in the UK. Under current legislation, drivers exceeding this threshold can be prosecuted, whether or not their driving appears impaired.
Yet in multiple driving scenarios, the researchers found no significant difference between the cannabis-using group and the control group.
Participants in the cannabis group consumed products containing on average 30 % of THC and 0.6 % of CBD, inhaling about 159 mg THC. They were tested using four simulator scenarios designed to measure key indicators such as speed regulation, reaction time, following distance and trajectory control.
Research focused on the SDLP (standard deviation of lateral position), generally considered the most reliable indicator of cannabis-related impairment of driving ability, as it measures the amplitude of a vehicle's «zigzags» in its lane.
Surprisingly, the control group actually showed slightly higher SDLP scores under both standard and distracted driving conditions. These differences were small and not statistically significant.
Other parameters, such as speed and reaction time, also showed no difference. The number of collisions was too low to enable pertinent analysis.
Feeling high doesn't mean driving while impaired
The study revealed a discrepancy between subjective intoxication and objective driving performance. Cannabis users reported significantly higher levels of self-reported intoxication, at around 30 out of 100 on visual analog scales. They also felt that cannabis had affected their driving more than the control group.
Despite this perception, their performance showed no measurable impairment.
Another conclusion is that the researchers found no clear correlation between the THC percentage consumed and driving impairment measures.
Similarly, the THC in blood and THC in saliva were not correlated with driving performance. The researchers did, however, note a possible trend concerning the 11-hydroxy-THC (11-OH-THC), an active metabolite, although the evidence is not conclusive.
The authors of the study point out that their results apply specifically to regular users, i.e. those who consume cannabis. four to seven times a week. Many of the participants were daily consumers with an average age of 12 years of cannabis use, suggesting a strong tolerance profile.
Researchers warn that occasional users may react differently and suffer longer-lasting alterations. They also point out that edibles can result in longer-lasting THC levels in the blood than inhaled cannabis, which could affect driving for prolonged periods.
For the time being, this study adds to the evidence more and more according to which THC limits are not a reliable measure of driving risk on their own, especially among experienced users or medical patients who are, for the time being in the French experiment, forbidden to drive.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe3 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in Ireland4 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Cannabis in the U.S.3 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Switzerland4 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project
-
Cannabis in France4 weeks ago
Reunion Island: The CBD Cannabis Cup Returns to Jardin Maniron on August 16, 2026
-
Business2 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon


You must be logged in to post a comment Login